FAKTOR OPTIONSSCHEIN - BOSTON SCIENTIFIC | Market Closed - Börse Stuttgart 05:16:29 2024-06-21 am EDT | ||
| 89.12 EUR | -0.67% |
|
| Current month | +9.44% | ||
| 1 month | -0.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-21 | 89.12 | -0.67% |
| 24-06-20 | 89.72 | -0.34% |
| 24-06-19 | 90.03 | +4.48% |
| 24-06-18 | 86.17 | -10.57% |
| 24-06-17 | 96.36 | +5.98% |
Delayed Quote Börse Stuttgart
Last update June 21, 2024 at 05:16 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | Goldman Sachs |
| WKN | GK6YGE |
| ISIN | DE000GK6YGE5 |
| Date issued | 2022-06-28 |
| Strike | 66 $ |
| Maturity | Unlimited |
| Parity | 0.11 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 102.3 € |
|---|---|
| Lowest since issue | 7.49 € |
| Spread | 3 € |
| Spread % | 2.90% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
77.71
USD
Average target price
82.35
USD
Spread / Average Target
+5.98%
- Stock Market
- Certificates
- Certificat
